Liu Song Yin
Chief Executive Officer at Sunho Biologics, Inc.
Profile
Liu Song Yin is currently the CEO, Executive Director & Chief Scientific Officer at Sunho Biologics, Inc. and the Chief Executive & Scientific Officer at SunHo (China) Biopharmaceutical Co. Ltd.
He previously worked as an Executive Director at Genscript Biotech Corp.
Dr. Yin received his undergraduate degree from the University of Science & Technology of China in 2008.
Liu Song Yin active positions
| Companies | Position | Start |
|---|---|---|
Sunho Biologics, Inc.
 Sunho Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Sunho Biologics, Inc. is a biopharmaceutical company engaged in the development and commercialization of biologics that regulate immune microenvironment by directly modulating both the innate and adaptive immune systems. The company was founded on May 14, 2021 and is headquartered in Huzhou City, China. | Chief Executive Officer | 21/07/2023 |
| SunHo (China) Biopharmaceutical Co. Ltd. | Chief Executive Officer | 01/11/2020 |
Former positions of Liu Song Yin
| Companies | Position | End |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Board Member | 01/10/2020 |
Training of Liu Song Yin
| University of Science & Technology of China | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
 | Commercial Services |
| Private companies | 1 |
|---|---|
| SunHo (China) Biopharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Liu Song Yin
